I am not complaining that ANP is aiming dementia as next target, it is just too soon to talk about it as there is no proven evidences at the stage. step by step, I wish ANP could copy the the story for CUV, fingers crossed!
Ann: US FDA Feedback on Type C Meeting for ATL1102 in the US, page-177
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15269 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 37037 | 1 |
View Market Depth
| Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable